Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Indexes  >  Australian Stock Exchange  >  S&P/ASX 200    XJO   XC0006013624

S&P/ASX 200

(XJO)
SummaryQuotesChartsNewsHeatmapComponents 
SummaryAll NewsNews of the index componentsMarketScreener Strategies


Within the index, exceptional career paths

share with twitter share with LinkedIn share with facebook
Mid-term Analysis published on 11/12/2019 | 10:13am

At the other end of the planet, the Australian Enlarged Index, the S&P/ASX 200, achieved a good 2019 vintage, accumulating more than 19.7% since the beginning of the year.

The 200 stocks in the Sydney Stock Exchange Index have diverging paths. Nevertheless, the majority are in the green since 80% are performing positively. The top prize went to Polynovo, a biopharma company, with a 271% increase. The Melbourne laboratory is currently focusing on the development and commercialization of innovative medical devices using its technology in the treatment of burns, surgical wounds and negative pressure therapy. Jumbo Interactive   (lottery reseller) replicates this exceptional track record with its 193%. On the other hand, Costa Group (fruit and vegetable producer) is picking up sharply, with a decrease of more than 60% Graphically, in daily data, the index returns to test the 6775-point line for the fourth time within two months. Driven by upward moving averages, prices could reach the higher technical level close to 6850 points, zenith inscribed this summer. The powerful upward trend is therefore expected to continue.

share with twitter share with LinkedIn share with facebook

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Chart S&P/ASX 200
Duration : Period :
S&P/ASX 200 Technical Analysis Chart | MarketScreener
Full-screen chart
Heatmap :